Sanuwave Health (SNWV) Competitors $16.69 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$16.68 -0.01 (-0.06%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNWV vs. MDXG, NPCE, TCMD, KIDS, and BBNXShould you buy Sanuwave Health stock or one of its competitors? MarketBeat compares Sanuwave Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sanuwave Health include MiMedx Group (MDXG), NeuroPace (NPCE), Tactile Systems Technology (TCMD), OrthoPediatrics (KIDS), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. SNWV vs. MDXGSNWV vs. NPCESNWV vs. TCMDSNWV vs. KIDSSNWV vs. BBNXHow does Sanuwave Health compare to MiMedx Group?MiMedx Group (NASDAQ:MDXG) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Which has higher valuation and earnings, MDXG or SNWV? MiMedx Group has higher revenue and earnings than Sanuwave Health. MiMedx Group is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$418.63M1.29$48.58M$0.2018.10Sanuwave Health$44.05M3.26$11.81M$0.3350.58 Does the media prefer MDXG or SNWV? In the previous week, MiMedx Group had 3 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for MiMedx Group and 0 mentions for Sanuwave Health. MiMedx Group's average media sentiment score of 0.22 beat Sanuwave Health's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the media. Company Overall Sentiment MiMedx Group Neutral Sanuwave Health Neutral Which has more risk and volatility, MDXG or SNWV? MiMedx Group has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Is MDXG or SNWV more profitable? Sanuwave Health has a net margin of 35.96% compared to MiMedx Group's net margin of 7.88%. MiMedx Group's return on equity of 21.03% beat Sanuwave Health's return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group7.88% 21.03% 15.92% Sanuwave Health 35.96%-450.56%44.87% Do insiders & institutionals hold more shares of MDXG or SNWV? 79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts rate MDXG or SNWV? MiMedx Group presently has a consensus target price of $8.50, indicating a potential upside of 134.81%. Sanuwave Health has a consensus target price of $51.00, indicating a potential upside of 205.57%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 SummaryMiMedx Group beats Sanuwave Health on 9 of the 17 factors compared between the two stocks.How does Sanuwave Health compare to NeuroPace?Sanuwave Health (NASDAQ:SNWV) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability. Do insiders and institutionals have more ownership in SNWV or NPCE? 42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Comparatively, 20.5% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer SNWV or NPCE? Sanuwave Health currently has a consensus target price of $51.00, suggesting a potential upside of 205.57%. NeuroPace has a consensus target price of $18.83, suggesting a potential upside of 11.31%. Given Sanuwave Health's higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50NeuroPace 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.88 Does the media favor SNWV or NPCE? In the previous week, NeuroPace had 6 more articles in the media than Sanuwave Health. MarketBeat recorded 6 mentions for NeuroPace and 0 mentions for Sanuwave Health. NeuroPace's average media sentiment score of 0.51 beat Sanuwave Health's score of 0.00 indicating that NeuroPace is being referred to more favorably in the news media. Company Overall Sentiment Sanuwave Health Neutral NeuroPace Positive Which has more risk and volatility, SNWV or NPCE? Sanuwave Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, NeuroPace has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market. Is SNWV or NPCE more profitable? Sanuwave Health has a net margin of 35.96% compared to NeuroPace's net margin of -21.67%. NeuroPace's return on equity of -108.20% beat Sanuwave Health's return on equity.Company Net Margins Return on Equity Return on Assets Sanuwave Health35.96% -450.56% 44.87% NeuroPace -21.67%-108.20%-18.50% Which has better valuation & earnings, SNWV or NPCE? Sanuwave Health has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanuwave Health$44.05M3.26$11.81M$0.3350.58NeuroPace$99.99M5.77-$21.47M-$0.65N/A SummaryNeuroPace beats Sanuwave Health on 11 of the 17 factors compared between the two stocks.How does Sanuwave Health compare to Tactile Systems Technology?Tactile Systems Technology (NASDAQ:TCMD) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Which has preferable valuation and earnings, TCMD or SNWV? Tactile Systems Technology has higher revenue and earnings than Sanuwave Health. Tactile Systems Technology is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTactile Systems Technology$329.52M1.70$19.09M$0.8828.30Sanuwave Health$44.05M3.26$11.81M$0.3350.58 Does the media prefer TCMD or SNWV? In the previous week, Tactile Systems Technology had 6 more articles in the media than Sanuwave Health. MarketBeat recorded 6 mentions for Tactile Systems Technology and 0 mentions for Sanuwave Health. Tactile Systems Technology's average media sentiment score of 0.39 beat Sanuwave Health's score of 0.00 indicating that Tactile Systems Technology is being referred to more favorably in the media. Company Overall Sentiment Tactile Systems Technology Neutral Sanuwave Health Neutral Do insiders & institutionals hold more shares of TCMD or SNWV? 83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 14.4% of Sanuwave Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is TCMD or SNWV more profitable? Sanuwave Health has a net margin of 35.96% compared to Tactile Systems Technology's net margin of 5.91%. Tactile Systems Technology's return on equity of 9.70% beat Sanuwave Health's return on equity.Company Net Margins Return on Equity Return on Assets Tactile Systems Technology5.91% 9.70% 7.53% Sanuwave Health 35.96%-450.56%44.87% Do analysts prefer TCMD or SNWV? Tactile Systems Technology currently has a consensus price target of $38.60, indicating a potential upside of 55.02%. Sanuwave Health has a consensus price target of $51.00, indicating a potential upside of 205.57%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Tactile Systems Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tactile Systems Technology 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Which has more volatility and risk, TCMD or SNWV? Tactile Systems Technology has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. SummaryTactile Systems Technology beats Sanuwave Health on 9 of the 16 factors compared between the two stocks.How does Sanuwave Health compare to OrthoPediatrics?Sanuwave Health (NASDAQ:SNWV) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Which has more risk & volatility, SNWV or KIDS? Sanuwave Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Is SNWV or KIDS more profitable? Sanuwave Health has a net margin of 35.96% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Sanuwave Health's return on equity.Company Net Margins Return on Equity Return on Assets Sanuwave Health35.96% -450.56% 44.87% OrthoPediatrics -16.31%-7.01%-4.86% Which has higher valuation & earnings, SNWV or KIDS? Sanuwave Health has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanuwave Health$44.05M3.26$11.81M$0.3350.58OrthoPediatrics$236.35M2.00-$39.65M-$1.68N/A Do analysts prefer SNWV or KIDS? Sanuwave Health presently has a consensus price target of $51.00, indicating a potential upside of 205.57%. OrthoPediatrics has a consensus price target of $24.44, indicating a potential upside of 33.07%. Given Sanuwave Health's higher probable upside, research analysts plainly believe Sanuwave Health is more favorable than OrthoPediatrics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.82 Do institutionals and insiders believe in SNWV or KIDS? 42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor SNWV or KIDS? In the previous week, OrthoPediatrics had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 1 mentions for OrthoPediatrics and 0 mentions for Sanuwave Health. OrthoPediatrics' average media sentiment score of 1.17 beat Sanuwave Health's score of 0.00 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Overall Sentiment Sanuwave Health Neutral OrthoPediatrics Positive SummarySanuwave Health and OrthoPediatrics tied by winning 8 of the 16 factors compared between the two stocks.How does Sanuwave Health compare to Beta Bionics?Sanuwave Health (NASDAQ:SNWV) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation. Is SNWV or BBNX more profitable? Sanuwave Health has a net margin of 35.96% compared to Beta Bionics' net margin of -60.27%. Beta Bionics' return on equity of -23.00% beat Sanuwave Health's return on equity.Company Net Margins Return on Equity Return on Assets Sanuwave Health35.96% -450.56% 44.87% Beta Bionics -60.27%-23.00%-20.55% Do insiders and institutionals believe in SNWV or BBNX? 42.5% of Sanuwave Health shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 5.3% of Beta Bionics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, SNWV or BBNX? Sanuwave Health has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.29, meaning that its share price is 229% more volatile than the broader market. Which has preferable earnings and valuation, SNWV or BBNX? Sanuwave Health has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanuwave Health$44.05M3.26$11.81M$0.3350.58Beta Bionics$100.25M5.25-$73.20M-$1.51N/A Does the media refer more to SNWV or BBNX? In the previous week, Beta Bionics had 5 more articles in the media than Sanuwave Health. MarketBeat recorded 5 mentions for Beta Bionics and 0 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 0.00 beat Beta Bionics' score of -0.22 indicating that Sanuwave Health is being referred to more favorably in the media. Company Overall Sentiment Sanuwave Health Neutral Beta Bionics Neutral Do analysts prefer SNWV or BBNX? Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 205.57%. Beta Bionics has a consensus target price of $20.00, indicating a potential upside of 69.20%. Given Sanuwave Health's higher probable upside, analysts clearly believe Sanuwave Health is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50Beta Bionics 1 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummarySanuwave Health beats Beta Bionics on 9 of the 16 factors compared between the two stocks. Get Sanuwave Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNWV vs. The Competition ExportMetricSanuwave HealthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$143.52M$8.52B$6.45B$12.34BDividend YieldN/A2.50%2.76%5.28%P/E Ratio50.5816.2421.2225.65Price / Sales3.268.28553.9286.28Price / Cash9.8317.1143.4956.67Price / Book79.484.0610.377.14Net Income$11.81M$224.05M$3.57B$335.98M7 Day Performance-1.01%4.68%6.01%3.56%1 Month Performance-10.75%-0.08%3.52%2.54%1 Year Performance-41.54%0.98%34.13%35.05% Sanuwave Health Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNWVSanuwave Health1.66 of 5 stars$16.69flat$51.00+205.6%-41.5%$143.52M$44.05M50.5840Gap UpMDXGMiMedx Group3.5425 of 5 stars$3.56+0.3%$8.50+138.8%-45.4%$530.25M$418.63M17.80870NPCENeuroPace2.9388 of 5 stars$15.36-2.7%$18.83+22.6%-4.3%$523.68M$99.99MN/A170Analyst RevisionTCMDTactile Systems Technology4.0117 of 5 stars$22.74-1.3%$38.60+69.7%+164.3%$512.92M$343.52M25.841,086KIDSOrthoPediatrics3.6737 of 5 stars$17.72-1.0%$24.44+37.9%-11.8%$455.14M$243.30MN/A200Positive News Related Companies and Tools Related Companies MDXG Competitors NPCE Competitors TCMD Competitors KIDS Competitors BBNX Competitors DCTH Competitors CLPT Competitors SI Competitors CV Competitors CARL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNWV) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanuwave Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanuwave Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
